Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EndoTAG-1 PK and Efficacy in Liver Metastases
NCT00542048Phase 2Completed
- Sponsor
- Medigene AG
- Start
- Nov 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of EndoTAG-1 in liver metastases, sponsored by Medigene AG. Primary endpoint: Pharmacokinetic profile. Started Nov 2007; status: completed.
02
Drugs
EndoTAG-1
03
Conditions
liver metastases
Beyond the preview
Go deeper on NCT00542048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542048.